OBSERVATION OF PREVALENCE OF NONALCOHOLIC FATTY LIVER DISEASE IN PREDIABETICS

Dr. Rahul Anand, Dr. Madan Pal Singh

Abstract


INTRODUCTION: Non-Alcoholic fatty liver disease is the most common chronic liver disease in most parts of the world, specially industrialized countries. NAFLD is strongly associated with overweight/obesity and insulin resistance. The simultaneous occurrence of NAFLD and type 2 diabetes is common. Hence, there is a strong possibility that NAFLD may be more prevalent among prediabetics than general population.

AIM: To find out prevalence of Non-Alcoholic Fatty liver disease in prediabetics.

METHODS: In this cross-sectional study, 50 diagnosed cases of prediabetics were compared with 50 euglycemic people after random selection from OPD for NAFLD by using various biochemical parameters and ultrasonography.

RESULT: It was found that 40% of prediabetic population has NAFLD compared to only 16% in control population. The difference was significant (p=0.0135).

CONCLUSION: So we conclude that prediabetes is an independent risk factor for the development of NAFLD.

Keywords


Pre-diabetics, Non alcoholic fatty liver disease

Full Text:

PDF

References


Smith BW, Adams LA Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment. Nat Rev Endocrinol 2011;7:456–465pmid:21556019

Gupte P, Amarapurkar D, Agal S, et al. Non-alcoholic steatohepatitis in type 2 diabetes mellitus. J Gastroenterol Hepatol 2004;19:854–858pmid:15242486

Sanchez P.P., Bril F., Maximos M., Lomonaco R., Biernacki D., Orsak B. High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and normal plasma aminotransferase levels. J Clin Endocrinol Metab. 2015:jc20151966.

Williamson R.M., Price J.F., Glancy S., Perry E., Nee L.D., Hayes P.C. Prevalence of and risk factors for hepatic steatosis and nonalcoholic fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care. 2011;34:1139–1144.

Sung K.-C., Kim S.H. Interrelationship between fatty liver and insulin resistance in the development of type 2 diabetes. J Clin Endocrinol Metab. 2011;96:1093–1097.

Armstrong M.J., Hazlehurst J.M., Parker R., Koushiappi E., Mann J., Khan S. Severe asymptomatic non-alcoholic fatty liver disease in routine diabetes care; a multi-disciplinary team approach to diagnosis and management. QJM. 2014;107:33–41.


Refbacks

  • There are currently no refbacks.